Comparing treatments for chronic hives
Part of Immune system & allergy, Skin clinical trials.
This study compares different treatment options for people with chronic hives (urticaria) that last longer than 6 weeks. It aims to find which treatment works best to reduce itching and welts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 13 and 60 years old.
- You should have had hives (itchy red welts) for more than 6 weeks.
- You cannot be pregnant or breastfeeding.
- You must not have a weakened immune system, or chronic liver or kidney disease.
- You cannot have taken steroid medications (like prednisone) in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a small amount of your own blood (called autologous whole blood) can help reduce chronic hives that haven't improved with regular antihistamines. If you join, you may get this treatment and the researchers will see if it helps your symptoms.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
This study tests a low-dose immune therapy (interleukin-2) for people with chronic hives that don't get better with standard allergy pills. If you are an adult with ongoing hives and itching despite daily antihistamines, this trial might offer a new treatment option.
This trial tests whether a higher dose of cetirizine (an allergy medicine) works better than the standard dose for treating sudden hives in adults. It may help people who have had new hives in the last day and are not taking certain other medicines.
Hear when a new Chronic Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.